The Enlarged Board of Appeal in the case G02/08 had to decide about patentability of a claim differing from the prior art solely in the dosage regimen for applying a known pharmaceutical compound or medicament for a known indication.
The Enlarged Board of Appeal came to the conclusion that such a claim is allowable since any difference of a claimed subject matter compared to the prior art resulting in an unexpected effect can establish patentability.
Dr. Barbara Engels